nach oben

Pediatric Nephrology

Erschienen in:

29.03.2023 | Educational Review

Use of extracorporeal therapies to treat life-threatening intoxications

verfasst von: Kyle Deville, Nathan Charlton, David Askenazi

Erschienen in: Pediatric Nephrology | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Toxic ingestions are a significant cause of pediatric morbidity and mortality, with some requiring extracorporeal removal for therapy. Given the emergent and life-threatening nature of such scenarios, it is paramount that clinicians caring for intoxicated children be familiar with the subject. This review summarizes the following: (a) the properties of a substance which lend it amenable to removal; (b) the current extracorporeal treatment modalities available for such removal (of which hemodialysis is typically the ideal choice); (c) an introduction and framework to use a quick reference guide from the Extrip organization, which has a website available to guide clinicians’ rapid decisions; and (d) new membranes/approaches that may optimize clearance of certain intoxications.

Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Brooks DE, Dibert KW, Rivers LJ, Pham NPT, Ryan ML (2020) 2019 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 37th Annual Report. Clin Toxicol (Phila) 58:1360–1541CrossRefPubMed

Raina R, Grewal MK, Blackford M, Symons JM, Somers MJ, Licht C, Basu RK, Sethi SK, Chand D, Kapur G (2019) Renal replacement therapy in the management of intoxications in children: recommendations from the Pediatric Continuous Renal Replacement Therapy (PCRRT) workgroup. Pediatr Nephrol 34:2427–2448CrossRefPubMed

Tyagi PK, Winchester JF, Feinfeld DA (2008) Extracorporeal removal of toxins. Kidney Int 74:1231–1233CrossRefPubMed

Mirrakhimov AE, Barbaryan A, Gray A, Ayach T (2016) The role of renal replacement therapy in the management of pharmacologic poisonings. Int J Nephrol 2016

Levy G, Yaffe SJ (1974) Relationship between dose and apparent volume of distribution of salicyiate in children. Pediatr Res 8:365–365CrossRef

Øie S (1986) Drug distribution and binding. J Clin Pharmacol 26:583–586CrossRefPubMed

Mansoor A, Mahabadi N (2022) Volume of distribution. StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL. https://www.ncbi.nlm.nih.gov/books/NBK545280/

Meyer TW (2012) The removal of protein-bound solutes by dialysis. J Ren Nutr 22:203–206CrossRefPubMed

Dudley MN, Shyu W, Nightingale C, Quintiliani R (1986) Effect of saturable serum protein binding on the pharmacokinetics of unbound cefonicid in humans. Antimicrob Agents Chemother 30:565–569CrossRefPubMedPubMedCentral

10.

Allawati H, Dallas L, Nair S, Palmer J, Thaikandy S, Hutchison C (2020) A pharmacokinetic study comparing the clearance of vancomycin during haemodialysis using medium cut-off membrane (theranova) and high-flux membranes (revaclear). Toxins 12:317CrossRefPubMedPubMedCentral

11.

Weidhase L, Haussig E, Haussig S, Kaiser T, de Fallois J, Petros S (2019) Middle molecule clearance with high cut-off dialyzer versus high-flux dialyzer using continuous veno-venous hemodialysis with regional citrate anticoagulation: a prospective randomized controlled trial. PLoS One 14:e0215823CrossRefPubMedPubMedCentral

12.

Amyot S-L, Leblanc M, Thibeault Y, Geadah D, Cardinal J (1999) Myoglobin clearance and removal during continuous venovenous hemofiltration. Intensive Care Med 25:1169–1172CrossRefPubMed

13.

Ghannoum M, Hoffman RS, Gosselin S, Nolin TD, Lavergne V, Roberts DM (2018) Use of extracorporeal treatments in the management of poisonings. Kidney Int 94:682–688CrossRefPubMed

14.

De Pont AC (2007) Extracorporeal treatment of intoxications. Curr Opin Crit Care 13:668–673CrossRefPubMed

15.

Mégarbane B (2010) Treatment of patients with ethylene glycol or methanol poisoning: focus on fomepizole. Open Access Emerg Med 2:67CrossRefPubMedPubMedCentral

16.

Warady BA, Schaefer F, Alexander SR (2011) Pediatric dialysis. Third edition. Springer Nature Switzerland, Cham

17.

Churchill BM, Patri P (2021) The nitty-gritties of Kt/Vurea calculations in hemodialysis and peritoneal dialysis. Indian J Nephrol 31:97CrossRefPubMedPubMedCentral

18.

Kane SL, Constantiner M, Staubus AE, Meinecke CD, Sedor JR (2000) High-flux hemodialysis without hemoperfusion is effective in acute valproic acid overdose. Ann Pharmacother 34:1146–1151CrossRefPubMed

19.

Sikma M, Van den Broek M, Meulenbelt J (2012) Increased unbound drug fraction in acute carbamazepine intoxication: suitability and effectiveness of high-flux haemodialysis. Intensive Care Med 38:916–917CrossRefPubMedPubMedCentral

20.

Vijayan A, Palevsky PM (2012) Dosing of renal replacement therapy in acute kidney injury. Am J Kidney Dis 59:569–576CrossRefPubMedPubMedCentral

21.

Spinale JM, Laskin BL, Sondheimer N, Swartz SJ, Goldstein SL (2013) High-dose continuous renal replacement therapy for neonatal hyperammonemia. Pediatr Nephrol 28:983–986CrossRefPubMedPubMedCentral

22.

Ahmed S, Kaplan A (2020) Therapeutic plasma exchange using membrane plasma separation. Clin J Am Soc Nephrol 15:1364–1370CrossRefPubMedPubMedCentral

23.

Ward DM (2011) Conventional apheresis therapies: a review. J Clin Apher 26:230–238CrossRefPubMed

24.

Szczepiorkowski ZM, Winters JL, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R, Schwartz J, Weinstein R, Shaz BH (2010) Guidelines on the use of therapeutic apheresis in clinical practice—evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 25:83–177CrossRefPubMed

25.

Schutt RC, Ronco C, Rosner MH (2012) The role of therapeutic plasma exchange in poisonings and intoxications. Semin Dial 25:201–206CrossRefPubMed

26.

Peszynski P, Klammt S, Peters E, Mitzner S, Stange J, Schmidt R, Peszynski P, Klammt S, Peters E, Mitzner S (2002) Albumin dialysis: single pass vs. recirculation (MARS). Liver 22:40–42CrossRefPubMed

27.

Vilay AM, Mueller BA, Haines H, Alten JA, Askenazi DJ (2010) Treatment of methotrexate intoxication with various modalities of continuous extracorporeal therapy and glucarpidase. Pharmacotherapy 30:111CrossRefPubMed

28.

Kıhtır HS, Yıldırım HM, Yeşilbaş O, Duramaz BB, Şevketoğlu E (2016) Single-pass albumin dialysis in a child aged six months with phenobarbital poisoning. Turk Arch Pediatr 51:228CrossRef

29.

Chung YK, Chang KY, Park HS, Kim MH, Lee KM, Lim TS, Kim HW (2014) Severe carbamazepine intoxication unresponsive to albumin-enhanced continuous venovenous hemodiafiltration with low dialysate flow. Hemodial Int 18:551–555CrossRefPubMed

30.

Koivusalo AM, Yildirim Y, Vakkuri A, Lindgren L, Höckerstedt K, Isoniemi H (2003) Experience with albumin dialysis in five patients with severe overdoses of paracetamol. Acta Anaesthesiol Scand 47:1145–1150CrossRefPubMed

31.

McIntyre CW, Fluck RJ, Freeman JG, Lambie SH (2002) Use of albumin dialysis in the treatment of hepatic and renal dysfunction due to paracetamol intoxication. Nephrol Dial Transplant 17:316–317CrossRefPubMed

32.

Pichon N, François B, Clavel M, Vignon P, Chevreuil C, Michel Gaulier J (2006) Albumin dialysis: a new therapeutic alternative for severe diltiazem intoxication. Clin Toxicol 44:195–196CrossRef

33.

Dobisova A, Vavrinec P, Vavrincova-Yaghi D, Gebhardtova A, Henning RH, Yaghi A (2021) Case report: enhanced diazepam elimination with the molecular adsorbents recirculating system (MARS) in severe autointoxication: a survival case report. Front Med 8:189CrossRef

34.

Covic A, Goldsmith DJ, Gusbeth-Tatomir P, Volovat C, Dimitriu AG, Cristogel F, Bizo A (2003) Successful use of molecular absorbent regenerating system (MARS) dialysis for the treatment of fulminant hepatic failure in children accidentally poisoned by toxic mushroom ingestion. Liver Int 23:21–27CrossRefPubMed

35.

Prokurat S, Grenda R, Lipowski D, Kaliciński P, Migdal M, Prokurat S, Grenda R, Lipowski D, Kaliciński P, Migdal M (2002) MARS procedure as a bridge to combined liver–kidney transplantation in severe chromium–copper acute intoxication: a paediatric case report. Liver 22:76–77CrossRefPubMed

36.

Sen S, Ratnaraj N, Davies NA, Mookerjee RP, Cooper CE, Patsalos PN, Williams R, Jalan R (2003) Treatment of phenytoin toxicity by the molecular adsorbents recirculating system (MARS). Epilepsia 44:265–267CrossRefPubMed

37.

Korsheed S, Selby NM, Fluck RJ (2007) Treatment of severe theophylline poisoning with the molecular adsorbent recirculating system (MARS). Nephrol Dial Transplant 22:969–970CrossRefPubMed

38.

Wittebole X, Hantson P (2011) Use of the molecular adsorbent recirculating system (MARS™) for the management of acute poisoning with or without liver failure. Clin Toxicol 49:782–793CrossRef

39.

Lavergne V, Nolin TD, Hoffman RS, Roberts D, Gosselin S, Goldfarb DS, Kielstein JT, Mactier R, Maclaren R, Mowry JB (2012) The EXTRIP (extracorporeal treatments in poisoning) workgroup: guideline methodology. Clin Toxicol 50:403–413CrossRef

Titel: Use of extracorporeal therapies to treat life-threatening intoxications
verfasst von: Kyle Deville
Nathan Charlton
David Askenazi
Publikationsdatum: 29.03.2023
Verlag: Springer Berlin Heidelberg
Erschienen in: Pediatric Nephrology / Ausgabe 1/2024
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI: https://doi.org/10.1007/s00467-023-05937-7

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Use of extracorporeal therapies to treat life-threatening intoxications

Abstract

Neu im Fachgebiet Pädiatrie

Embryotransfer erhöht womöglich Leukämierisiko der Kinder

Darf man die Behandlung eines Neonazis ablehnen?

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Häufigste Gründe für Brustschmerzen bei Kindern

Update Pädiatrie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2024

Novel variants in CRB2 targeting the malfunction of slit diaphragm related to focal segmental glomerulosclerosis

Isotonic versus hypotonic intravenous maintenance fluid therapy: what’s new?

A child with semaphorin 3b-associated membranous nephropathy effectively treated with obinutuzumab after rituximab resistance

Eculizumab in STEC-HUS: a paradigm shift in the management of pediatric patients with neurological involvement

Lipid abnormalities in pediatric kidney transplant recipients on steroid withdrawal maintenance immunosuppression

Malnutrition and protein energy wasting are associated with severity and progression of pediatric chronic kidney disease

Neu im Fachgebiet Pädiatrie

Embryotransfer erhöht womöglich Leukämierisiko der Kinder

Darf man die Behandlung eines Neonazis ablehnen?

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Häufigste Gründe für Brustschmerzen bei Kindern

Update Pädiatrie